| SOCS5 |
SOCS5, CIS6, CISH5, CISH6, KIAA0671: Suppressor of cytokine signaling 5 |
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
0.265 |
Evidence |
|
| GPR37L1 |
GPR37L1, ETBRLP2: Endothelin B receptor-like protein 2 precursor |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
0.265 |
Evidence |
|
| GPR37L1 |
GPR37L1, ETBRLP2: Endothelin B receptor-like protein 2 precursor |
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
0.265 |
Evidence |
|
| GPR37L1 |
GPR37L1, ETBRLP2: Endothelin B receptor-like protein 2 precursor |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
0.265 |
Evidence |
|
| GPR37L1 |
GPR37L1, ETBRLP2: Endothelin B receptor-like protein 2 precursor |
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
0.265 |
Evidence |
|
| MAFK |
MAFK: Transcription factor MafK |
BATF |
BATF: Basic leucine zipper transcriptional factor ATF-like |
0.265 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
0.265 |
Evidence |
|
| TLR2 |
TLR2, TIL4: Toll-like receptor 2 precursor |
SIGIRR |
SIGIRR, UNQ301/PRO342: Single Ig IL-1-related receptor |
0.265 |
Evidence |
|
| SSX5 |
SSX5: Protein SSX5 |
SCAND2 |
SCAND2: SCAN domain-containing protein 2 |
0.265 |
Evidence |
|
| SSX5 |
SSX5: Protein SSX5 |
ZSCAN5 |
ZSCAN5, ZNF495: Zinc finger and SCAN domain-containing protein 5 |
0.265 |
Evidence |
|
| TCF21 |
TCF21, POD1: Transcription factor 21 |
MXD4 |
MXD4, MAD4: Max-interacting transcriptional repressor MAD4 |
0.265 |
Evidence |
|
| TCF21 |
TCF21, POD1: Transcription factor 21 |
AHR |
AHR: Aryl hydrocarbon receptor precursor |
0.265 |
Evidence |
|
| HCRTR2 |
HCRTR2: Orexin receptor type 2 |
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
0.265 |
Evidence |
|
| KCNQ3 |
KCNQ3: Potassium voltage-gated channel subfamily KQT member 3 |
SCN11A |
SCN11A, PN5, SCN12A, SNS2: Sodium channel protein type 11 subunit alpha |
0.265 |
Evidence |
|
| KCNQ3 |
KCNQ3: Potassium voltage-gated channel subfamily KQT member 3 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
0.265 |
Evidence |
|
| KCNQ3 |
KCNQ3: Potassium voltage-gated channel subfamily KQT member 3 |
TRPC7 |
TRPC7, TRP7: Short transient receptor potential channel 7 |
0.265 |
Evidence |
|
| KCNQ3 |
KCNQ3: Potassium voltage-gated channel subfamily KQT member 3 |
ITPR2 |
ITPR2: Inositol 1,4,5-trisphosphate receptor type 2 |
0.265 |
Evidence |
|
| RIPK2 |
RIPK2, CARDIAK, UNQ277/PRO314/PRO34092, RICK, RIP2: Receptor-interacting serine/ |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
0.265 |
Evidence |
|
| RIPK2 |
RIPK2, CARDIAK, UNQ277/PRO314/PRO34092, RICK, RIP2: Receptor-interacting serine/ |
THOC1 |
THOC1, HPR1: THO complex subunit 1 |
0.265 |
Evidence |
|
| RIPK2 |
RIPK2, CARDIAK, UNQ277/PRO314/PRO34092, RICK, RIP2: Receptor-interacting serine/ |
CASP10 |
IPI00290791 |
0.265 |
Evidence |
|
| RIPK2 |
RIPK2, CARDIAK, UNQ277/PRO314/PRO34092, RICK, RIP2: Receptor-interacting serine/ |
RANGAP1 |
RANGAP1, SD: Ran GTPase-activating protein 1 |
0.265 |
Evidence |
|
| KLK10 |
KLK10, NES1, PRSSL1: Kallikrein-10 precursor |
SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
0.265 |
Evidence |
|
| FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.265 |
Evidence |
O
|
| FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
0.265 |
Evidence |
|
| RS1 |
RS1, XLRS1: Retinoschisin precursor |
PRRG3 |
PRRG3, TMG3: Transmembrane gamma-carboxyglutamic acid protein 3 precursor |
0.265 |
Evidence |
|